NO985936L - Nasal administrasjon av desmopressin - Google Patents

Nasal administrasjon av desmopressin

Info

Publication number
NO985936L
NO985936L NO985936A NO985936A NO985936L NO 985936 L NO985936 L NO 985936L NO 985936 A NO985936 A NO 985936A NO 985936 A NO985936 A NO 985936A NO 985936 L NO985936 L NO 985936L
Authority
NO
Norway
Prior art keywords
desmopressin
nasal administration
nasal
administration
Prior art date
Application number
NO985936A
Other languages
English (en)
Other versions
NO985936D0 (no
Inventor
Bengt Bengtsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO985936D0 publication Critical patent/NO985936D0/no
Publication of NO985936L publication Critical patent/NO985936L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO985936A 1996-06-20 1998-12-17 Nasal administrasjon av desmopressin NO985936L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/667,047 US5763398A (en) 1996-06-20 1996-06-20 Nasal administration of desmopressin
PCT/SE1997/001010 WO1997048379A1 (en) 1996-06-20 1997-06-10 Nasal administration of desmopressin

Publications (2)

Publication Number Publication Date
NO985936D0 NO985936D0 (no) 1998-12-17
NO985936L true NO985936L (no) 1999-02-16

Family

ID=24676595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985936A NO985936L (no) 1996-06-20 1998-12-17 Nasal administrasjon av desmopressin

Country Status (24)

Country Link
US (1) US5763398A (no)
EP (1) EP0921786A1 (no)
JP (1) JP2000502358A (no)
KR (1) KR20000016781A (no)
CN (1) CN1233952A (no)
AU (1) AU707527B2 (no)
BR (1) BR9700797A (no)
CA (1) CA2258552A1 (no)
CZ (1) CZ420198A3 (no)
EE (1) EE9800453A (no)
HU (1) HUP9903541A3 (no)
IL (1) IL127572A (no)
LT (1) LT4621B (no)
LV (1) LV12230B (no)
NO (1) NO985936L (no)
NZ (1) NZ333124A (no)
PL (1) PL330902A1 (no)
RO (1) RO120170B1 (no)
RU (1) RU2173559C2 (no)
SI (1) SI9720040A (no)
SK (1) SK176998A3 (no)
TR (1) TR199802596T2 (no)
UA (1) UA49888C2 (no)
WO (1) WO1997048379A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP1530967B1 (en) * 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
ES2319054B1 (es) * 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
ES2596435T3 (es) * 2008-05-21 2017-01-09 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
AU2010260211B2 (en) 2008-12-22 2016-04-21 Acerus Pharmaceuticals USA, LLC Safe desmopressin administration
DK2381923T4 (da) * 2008-12-22 2023-09-11 Acerus Pharmaceuticals Usa Llc Intranasal administration af desmopressin
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
FR2954774B1 (fr) * 2009-10-30 2012-01-06 Michelin Soc Tech Methode de preparation d'un melange maitre de caoutchouc naturel et de silice
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
RU2605311C1 (ru) * 2015-07-14 2016-12-20 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ лечения болевого синдрома у больных с дегенеративно-дистрофическими заболеваниями позвоночника

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
HU221617B1 (hu) * 1993-06-29 2002-12-28 Ferring B.V. Vizes készítmény dezmopresszin nazális adagolására
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin

Also Published As

Publication number Publication date
LT4621B (lt) 2000-02-25
NZ333124A (en) 1999-05-28
CN1233952A (zh) 1999-11-03
HUP9903541A2 (hu) 2000-04-28
KR20000016781A (ko) 2000-03-25
BR9700797A (pt) 1998-10-06
SI9720040A (sl) 1999-08-31
NO985936D0 (no) 1998-12-17
AU707527B2 (en) 1999-07-15
IL127572A0 (en) 1999-10-28
CA2258552A1 (en) 1997-12-24
AU3280297A (en) 1998-01-07
US5763398A (en) 1998-06-09
LV12230A (lv) 1999-03-20
IL127572A (en) 2003-04-10
LV12230B (en) 1999-06-20
RO120170B1 (ro) 2005-10-28
PL330902A1 (en) 1999-06-07
EP0921786A1 (en) 1999-06-16
JP2000502358A (ja) 2000-02-29
LT98188A (en) 1999-11-25
TR199802596T2 (xx) 1999-03-22
SK176998A3 (en) 1999-05-07
EE9800453A (et) 1999-08-16
WO1997048379A1 (en) 1997-12-24
CZ420198A3 (cs) 1999-04-14
RU2173559C2 (ru) 2001-09-20
UA49888C2 (uk) 2002-10-15
HUP9903541A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
NO985936L (no) Nasal administrasjon av desmopressin
IT1284049B1 (it) Medicamento per somministrazione nasale
DE69619210D1 (de) Nasaler Dilatator
DE69617754D1 (de) Inhalator
DE69721369D1 (de) Inhalator
DE69723202D1 (de) Inhalatoren
NO993068D0 (no) Ny forbindelsesform
NO980484D0 (no) Inhalator
NO20001962D0 (no) Terapeutisk anvendelse av kinolinderivater
FI973596A0 (fi) Identifikation av talaktiviteten av en kaella
FI972292A0 (fi) Administrering av diabetes
IS4698A (is) Innúðatæki
DE69715219D1 (de) Inhalator
DK0830166T3 (da) Inhalationsapparat
ID18679A (id) Penggunaan terapi lanjutan
FI965204A0 (fi) Bromelaiinin lääkekäyttö
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
NO964044D0 (no) Fremgangsmåte for uttagning av fjellrom
ITMI962377A0 (it) Dilatatore nasale perfezionato
FI942576A0 (fi) Behandling av plasma
NO991148L (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
IS4842A (is) Hlutar í innúðatæki
FI974235A0 (fi) Ny bestaemningsmetod
KR970056487U (ko) 분무기동체의 개량구조
BR7600020U (pt) Dilatodor externo nasal

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application